Paula Stubbemann

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau et al. · The Lancet Respiratory Medicine · 2021 · 352 citations · Full text

Vaccination, Immunodeficiencies, Immunology +6

Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19

Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro et al. · Immunity · 2021 · 249 citations · Full text

Viral Persistence, Medicine, Viral Pathogenesis +9

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 212 citations · Full text

Accredited Diagnostic Parameters, Prognosis, Immunology +17

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

January Weiner, Phillip Suwalski, Manuel Holtgrewe et al. · EClinicalMedicine · 2021 · 101 citations · Full text

A proteomic survival predictor for COVID-19 patients in intensive care

Vadim Demichev, Pinkus Tober‐Lau, Tatiana Nazarenko et al. · PLOS Digital Health · 2022 · 62 citations · Full text

Global Healthcare Systems, Prognosis, Covid-19 Epidemiology +18